Revamping the ovarian tumour microenvironment with an oncolytic adenovirus yields enhanced tumour-infiltrating lymphocyte anti-tumour activity

被引：0
|
作者：
Santos, J. M. [1 ,2 ,3 ]
Heinio, C. [4 ]
Cervera-Carrascon, V. [1 ,2 ,3 ]
Siurala, M. [5 ]
Quixabeira, D. C. A. [4 ]
De Gruijl, T. [6 ,7 ]
Lassus, H. [1 ,8 ,9 ]
Kanerva, A. [1 ,8 ,9 ]
Hemminki, A. [1 ,2 ,3 ]
机构：
[1] Univ Helsinki, Translat Immunol Res Program, Helsinki, Finland
[2] Univ Helsinki, Dept Oncol, Helsinki, Finland
[3] TILT Biotherapeut, Helsinki, Finland
[4] Univ Helsinki, Canc Gene Therapy Grp, Fac Med, Translat Immunol Res Program, Helsinki, Finland
[5] TILT Biotherapeut Ltd, Helsinki, Finland
[6] Univ Med Ctr Amsterdam, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands
[7] Univ Med Ctr Amsterdam, Canc Ctr Amsterdam, Dept Radiat Oncol, Amsterdam, Netherlands
[8] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland
[9] Helsinki Univ Hosp, Helsinki, Finland
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
149P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] THE ANTI-TUMOUR ACTIVITY OF 6-AZAURACIL RIBOSIDE
    SORM, F
    KEILOVA, H
    EXPERIENTIA, 1958, 14 (06): : 215 - 215
  • [42] In vivo anti-tumour activity of novel Quinazoline derivatives
    Alapati, V.
    Noolvi, M. N.
    Manjula, S. N.
    Pallavi, K. J.
    Patel, H. M.
    Tippeswamy, B. S.
    Satyanarayana, S. V.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (13) : 1753 - 1764
  • [43] Anti-tumour activity of bisphosphonates in human myeloma cells
    Shipman, CM
    Rogers, MJ
    Apperley, JF
    Russell, RGG
    Croucher, PI
    LEUKEMIA & LYMPHOMA, 1998, 32 (1-2) : 129 - 138
  • [44] ANTI-TUMOUR ACTIVITY OF CARBOBENZOXY-L-ASPARAGINE
    SCHLESINGER, M
    GROSSOWICZ, N
    LICHTENSTEIN, N
    EXPERIENTIA, 1969, 25 (01): : 14 - +
  • [45] POLYAMINE-GLYCERALDEHYDE DERIVATIVE WITH ANTI-TUMOUR ACTIVITY
    NEISH, WJP
    ZEITSCHRIFT FUR KREBSFORSCHUNG UND KLINISCHE ONKOLOGIE, 1971, 76 (03): : 219 - &
  • [46] Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
    N Ioannou
    A G Dalgleish
    A M Seddon
    D Mackintosh
    U Guertler
    F Solca
    H Modjtahedi
    British Journal of Cancer, 2011, 105 : 1554 - 1562
  • [47] Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
    Ioannou, N.
    Dalgleish, A. G.
    Seddon, A. M.
    Mackintosh, D.
    Guertler, U.
    Solca, F.
    Modjtahedi, H.
    BRITISH JOURNAL OF CANCER, 2011, 105 (10) : 1554 - 1562
  • [48] Synthesis and anti-tumour activity evaluation of bergenin derivatives
    Yang, Yanxia
    Yan, Jianwei
    Yan, Fulin
    Yin, Yanyan
    Zhuang, Fangfang
    JOURNAL OF CHEMICAL RESEARCH, 2015, (10) : 590 - 593
  • [49] Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasms
    Daskalakis, Kosmas
    Tsoli, Marina
    Angelousi, Anna
    Kassi, Evanthia
    Alexandraki, Krystallenia, I
    Kolomodi, Denise
    Kaltsas, Gregory
    Koumarianou, Anna
    ENDOCRINE CONNECTIONS, 2019, 8 (06) : 641 - 653
  • [50] MODIFYING EFFECT OF CRYOPRESERVATION ON ANTI-TUMOUR ACTIVITY OF FLCS
    Goltsev, A. N.
    Bondarovich, N. A.
    Safranchuk, O. V.
    Ostankov, M. V.
    CRYOLETTERS, 2010, 31 (02) : 185 - 186
12345